BTIG Maintains Buy on Verastem, Raises Price Target to $24

BTIG analyst Jeet Mukherjee has maintained a Buy rating on Verastem (NASDAQ: VSTM) and increased the price target from $18 to $24. This adjustment reflects a positive outlook on the company's performance.